Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells

about

Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells

Item

http://www.wikidata.org/entity/Q57493800

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@en

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@nl

type

Item

label

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@en

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@nl

prefLabel

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@en

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@nl

P1476

Eukaryotic translation initiat ...... squamous cell carcinoma cells

@en

P2093

Guizhou Xiao

http://www.w3.org/2001/XMLSchema#string

Lei Xie

http://www.w3.org/2001/XMLSchema#string

Li Gao

http://www.w3.org/2001/XMLSchema#string

Liang Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of eukaryotic initiation factor 5A-2

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Cancer statistics, 2016

A molecular signature of metastasis in primary solid tumors

A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers.

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.

A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer

Oral cancer: Current role of radiotherapy and chemotherapy.

P304

3479-3488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.26136

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30310504

http://www.w3.org/2001/XMLSchema#string

P932

6171023

http://www.w3.org/2001/XMLSchema#string